Home
Goldman Sachs Group reported a 2% stake in Fate Therapeutics FATE · 2,274,020.09 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2%
- Last report
- 7.4% · filed 25/05/09
- Shares held
- 2,274,020.09 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Goldman Sachs Group
- Event date
- 25/06/30
- Filed
- 25/08/14
2% stake · below 5%
- Stake
- 2%
- Last report
- 7.4%
- Since last report
- −5.4pp
Fate Therapeutics trades, last 26 weeks
What else happened in Fate Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Goldman Sachs Group's other 5% stake reports
- Goldman Sachs Group
5% stakeFuture Money Acquisition
5% stakeFuture Money Acquisition
FMAC
7.5% stake
1,184,873 sh
7.5% stake
Filed 08/14
- Goldman Sachs Group
5% stakeBreeze Acquisition Corp. II
5% stakeBreeze Acquisition Corp. II
BREZ
6.7% stake
970,701 sh
6.7% stake
Filed 08/14
- Goldman Sachs Group
5% stakeAmerican Exceptionalism Acquisition Corp. A
5% stakeAmerican Exceptionalism Acquisition Corp. A
AEXA
4.2% stake
1,444,735 sh
4.2% stake
Filed 08/14
- Goldman Sachs Group
5% stakeApex Tech Acquisition
5% stakeApex Tech Acquisition
TRAD
7.6% stake
1,076,558 sh
7.6% stake
Filed 08/14
- Goldman Sachs Group
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
6% stake
9,742,402.8 sh
6% stake
Filed 08/14
